Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Cited by CrossRef (122)

  1. Nitish Verma, Vandana Tayal, Vandana Roy. Proton Pump Inhibitors: Prescribing Practices, Appropriateness of Use, and Cost Incurred in a Tertiary Care, Public, Teaching Hospital in New Delhi, India. MAMC J Med Sci 2019;5:113
    https://doi.org/10.4103/mamcjms.mamcjms_40_19
  2. L Brand, SF Steyn, DW Wolmarans. Taking the ‘sauer’ out of sauerkraut: a rapid update on the pathophysiology and treatment of gastro-oesophageal reflux disease. SAGP 2020:42
    https://doi.org/10.36303/SAGP.2020.1.1.0002
  3. V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, A. A. Sheptulin, V. I. Simanenkov, T. L. Lapina, I. B. Khlynov, N. N. Dekhnich, O. D. Lopina, O. P. Alekseeva, N. V. Korochanskaya, M. F. Osipenko, P. V. Pavlov, S. S. Pirogov, G. N. Tarasova, Yu. P. Uspenskiy, D. N. Andreev, D. E. Rumyantseva. Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:7
    https://doi.org/10.22416/1382-4376-2020-30-6-7-18
  4. Hina Siddiqui, Aaminat Qureshi, Majid Khan, Atia‐tul Wahab, Muhammad Iqbal Choudhary. Retracted: Functionalization of 2‐Amino‐4‐chloropyridine as Potential In Vitro Inhibitors of Urease Enzyme: Synthesis, Kinetics and In Silico Studies. ChemistrySelect 2022;7
    https://doi.org/10.1002/slct.202201437
  5. Kate N. Wang, J. Simon Bell, Edwin C. K. Tan, Julia F. M. Gilmartin-Thomas, Michael J. Dooley, Jenni Ilomäki. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case–Control Study. Drugs Aging 2019;36:1027
    https://doi.org/10.1007/s40266-019-00704-6
  6. Michael Habs, Michael Koller. Material Risks of Homeopathic Medicinal Products: Regulatory Frameworks, Results of Preclinical Toxicology, and Clinical Meta-Analyses and Their Implications. Complement Med Res 2021;28:64
    https://doi.org/10.1159/000507952
  7. Manjunatha E, Nandeesh R., Syed Mansoor Ahmed. Antiulcer and Ulcer Healing Potential of Some Medicinal Plants: A Review. RJPP 2022:37
    https://doi.org/10.52711/0975-4385.2022.00009
  8. Aditya A. Joshi, Pankaj P. Nerkar. Determination of Proton Pump Inhibitors by Spectrophotometric, Chromatographic and by Hyphenated Techniques: A Review. Critical Reviews in Analytical Chemistry 2020:1
    https://doi.org/10.1080/10408347.2020.1750339
  9. Ajinkya Trimukhe, Satish Rojekar, Pradeep R. Vavia, R.R. Deshmukh. Pulsed plasma surface modified omeprazole microparticles for delayed release application. Journal of Drug Delivery Science and Technology 2021;66:102905
    https://doi.org/10.1016/j.jddst.2021.102905
  10. Shun Fujimoto, Nanae Tsuruoka, Motohiro Esaki, Ayako Takamori, Yasuhisa Sakata, Ryo Shimoda, Takashi Akutagawa, Koichi Node, Keizo Anzai, Nobuyuki Sugisaki, Ryuichi Iwakiri, Kuniaki Takagi, Kohei Yamanouchi, Kazuma Fujimoto. Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients. J. Clin. Biochem. Nutr. 2021;68:95
    https://doi.org/10.3164/jcbn.20-153
  11. Sadia Tasnim, Aaron L. Miller, Daniel C. Jupiter, Catherine F. Hamilton, Gabriel L. Reep, Timothy S. Krill, Richard B. Pyles, Ikenna C. Okereke. Effects of proton pump inhibitor use on the esophageal microbial community. BMC Gastroenterol 2020;20
    https://doi.org/10.1186/s12876-020-01460-3
  12. Ntombikayise Tembe, Kgothatso E. Machaba, Umar Ndagi, Hezekiel M. Kumalo, Ndumiso N. Mhlongo. Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase—a molecular modelling perspective. J Mol Model 2022;28
    https://doi.org/10.1007/s00894-021-04993-w
  13. Hsiu-Man Lien, Yu-Yen Wang, Mei-Zi Huang, Hui-Yu Wu, Chao-Lu Huang, Chia-Chi Chen, Shao-Wen Hung, Chia-Chang Chen, Cheng-Hsun Chiu, Chih-Ho Lai. Gastroprotective Effect of Anisomeles indica on Aspirin-Induced Gastric Ulcer in Mice. Antioxidants 2022;11:2327
    https://doi.org/10.3390/antiox11122327
  14. Ji-Hee Kim, Jae-Keun Oh, Yoo-Hwan Kim, Mi-Jung Kwon, Joo-Hee Kim, Hyo-Geun Choi. Association between Proton Pump Inhibitor Use and Parkinson’s Disease in a Korean Population. Pharmaceuticals 2022;15:327
    https://doi.org/10.3390/ph15030327
  15. Ya Qi Song, Yong Li, Su Li Zhang, Jie Gao, Shun Yi Feng, Gianluigi Forloni. Proton pump inhibitor use does not increase dementia and Alzheimer’s disease risk: An updated meta-analysis of published studies involving 642305 patients. PLoS ONE 2019;14:e0219213
    https://doi.org/10.1371/journal.pone.0219213
  16. Michael Rudenko. The Role of Co-Factors in Mast Cell Activation. EMJ Allergy Immunol 2023
    https://doi.org/10.33590/emjallergyimmunol/10301305
  17. Muhammad Miftahussurur, Boby Pratama Putra, Yoshio Yamaoka. The Potential Benefits of Vonoprazan as Helicobacter pylori Infection Therapy. Pharmaceuticals 2020;13:276
    https://doi.org/10.3390/ph13100276
  18. Kamonphat Wongtaweepkij, Nutchwarang Sup-adulchai, Jirath Chanachoat, Janet Krska, Narumol Jarernsiripornkul. Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand. PPA 2023;Volume 17:883
    https://doi.org/10.2147/PPA.S397557
  19. Lisanne M. M. Gommers, Joost G. J. Hoenderop, Jeroen H. F. de Baaij. Mechanisms of proton pump inhibitor‐induced hypomagnesemia. Acta Physiologica 2022;235
    https://doi.org/10.1111/apha.13846
  20. Sineenart Sanpinit, Piriya Chonsut, Chuchard Punsawad, Palika Wetchakul. Gastroprotective and Antioxidative Effects of the Traditional Thai Polyherbal Formula Phy-Blica-D against Ethanol-Induced Gastric Ulcers in Rats. Nutrients 2021;14:172
    https://doi.org/10.3390/nu14010172
  21. Anthony Wilks, Ladan Panahi, George Udeani, Salim Surani. Gastroesophageal Reflux Disease - A Growing Concern. 2021.
    https://doi.org/10.5772/intechopen.106338
  22. Naren Nallapeta, Jessica L. Reynolds, Smita Bakhai. Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic. 2020;54:864
    https://doi.org/10.1097/MCG.0000000000001317
  23. Samuel P. Banting, Henry E. Badgery, Matthew Read, Hiroshi Mashimo. Rethinking gastroesophageal reflux disorder. Annals of the New York Academy of Sciences 2020;1482:177
    https://doi.org/10.1111/nyas.14478
  24. Naohi Isse, Masashi Hashimoto. Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. BMJ Case Rep 2020;13:e235385
    https://doi.org/10.1136/bcr-2020-235385
  25. Gwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, Hong Jun Park, Sung Woo Jung, Ok-Jae Lee, Hyungkil Kim, Hoon Jai Chun, Soo Teik Lee, Ji Won Kim, Han Ho Jeon, Il-Kwun Chung, Hyun-Soo Kim, Dong Ho Lee, Kyoung-Oh Kim, Yun Jeong Lim, Seun-Ja Park, Soo-Jeong Cho, Byung-Wook Kim, Kwang Hyun Ko, Seong Woo Jeon, Jae Gyu Kim, In-Kyung Sung, Tae Nyeun Kim, Jae Kyu Sung, Jong-Jae Park. Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study. Gut and Liver 2021;15:841
    https://doi.org/10.5009/gnl20338
  26. Taned Chitapanarux, Nirush Lertprasertsuke, Acharaporn Kongnak. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in Helicobacter pylori-negative patients. Scandinavian Journal of Gastroenterology 2019;54:1199
    https://doi.org/10.1080/00365521.2019.1672781
  27. Poovadan Sudhakaran. Acupuncture for Hypertension Using Traditional Chinese Medicine Concepts. Medical Acupuncture 2021;33:15
    https://doi.org/10.1089/acu.2020.1422
  28. Michal Novotny, Blanka Klimova, Martin Valis. PPI Long Term Use: Risk of Neurological Adverse Events?. Front. Neurol. 2019;9
    https://doi.org/10.3389/fneur.2018.01142
  29. Jordan Guillot, Sandy Maumus-Robert, Alexandre Marceron, Pernelle Noize, Antoine Pariente, Julien Bezin. The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy. JCM 2020;9:3728
    https://doi.org/10.3390/jcm9113728
  30. Nurliana Abd Mutalib, Mohd Amirul Ariffin Mohd Rafi, Normala Abd Latip. Revisiting CYP2C9-Mediated drug-drug Interactions: A Review. RJPT 2021:6166
    https://doi.org/10.52711/0974-360X.2021.01068
  31. Raimunda SN Brilhante, Maria G da Rocha, Jonathas S de Oliveira, Jaime DA España, Vandbergue S Pereira, Débora de SCM Castelo-Branco, Waldemiro de A Pereira-Neto, José JC Sidrim, Rossana de A Cordeiro, Marcos FG Rocha. Proton pump inhibitors versus Cryptococcus species: effects on in vitro susceptibility and melanin production. Future Microbiology 2019;14:489
    https://doi.org/10.2217/fmb-2018-0340
  32. Khapre Meenakshi, Nautiyal Vinteshwari, Jagzape Minaxi, Saxena Vartika. Effectiveness of Ayurveda treatment in Urdhwaga Amlapitta: A clinical evaluation. Journal of Ayurveda and Integrative Medicine 2021;12:87
    https://doi.org/10.1016/j.jaim.2020.12.004
  33. Mohammad Sadegh Adel Mehraban, Meysam Shirzad, Mohammad Mahdi Ahmadian-Attari, Ramin Shakeri, Leila Mohamad Taghizadeh Kashani, Maliheh Tabarrai, Laila Shirbeigi. Effect of rose oil on Gastroesophageal Reflux Disease in comparison with omeprazole: A double-blind controlled trial. Complementary Therapies in Clinical Practice 2021;43:101361
    https://doi.org/10.1016/j.ctcp.2021.101361
  34. M.I. Zanaty, A. Abdel-Moneim, Y. Kitani, T. Sekiguchi, N. Suzuki. Влияние омепразола на остеобласты и остеокласты in vivo и в модели in vitro с использованием чешуи рыбы. БМ 2021;86:1423
    https://doi.org/10.31857/S032097252110002X
  35. G.M. Saiz Ladera, M.E. Pejenaute Labari, J.N. García Pascual. Actualización en la prescripción de inhibidores de la bomba de protones. Qué hacer y qué no hacer. Medicina de Familia. SEMERGEN 2021;47:267
    https://doi.org/10.1016/j.semerg.2020.09.011
  36. Tsutomu Yoshihara, Yosuke Oikawa, Takayuki Kato, Takaomi Kessoku, Takashi Kobayashi, Shingo Kato, Noboru Misawa, Keiichi Ashikari, Akiko Fuyuki, Hidenori Ohkubo, Takuma Higurashi, Yoko Tateishi, Yoshiki Tanaka, Shunji Nakajima, Hiroshi Ohno, Koichiro Wada, Atsushi Nakajima. The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin. Gut Microbes 2020;11:1385
    https://doi.org/10.1080/19490976.2020.1758290
  37. Lei Wang, Wen Li, Shuzhen Xin, Shuang Wu, Chenglu Peng, Hongyan Ding, Shibing Feng, Chang Zhao, Jinjie Wu, Xichun Wang. Soybean glycinin and β-conglycinin damage the intestinal barrier by triggering oxidative stress and inflammatory response in weaned piglets. Eur J Nutr 2023;62:2841
    https://doi.org/10.1007/s00394-023-03188-8
  38. Richard H. Hunt, Carmelo Scarpignato. Potent Acid Suppression with PPIs and P-CABs: What’s New?. Curr Treat Options Gastro 2018;16:570
    https://doi.org/10.1007/s11938-018-0206-y
  39. Ana Carolina Silveira Rabelo, Fernanda Caetano Camini, Melissa Maia Bittencourt, Kíssyla Lacerda, Wanderson Geraldo de Lima, Daniela Caldeira Costa. Baccharis trimera (carqueja) promotes gastroprotection on ethanol-induced acute gastric ulcer. ADV TRADIT MED (ADTM) 2020;20:563
    https://doi.org/10.1007/s13596-020-00466-2
  40. Toshihiko Kakiuchi, Yoshiki Tanaka, Hiroshi Ohno, Muneaki Matsuo, Kazuma Fujimoto. Helicobacter pylori infection-induced changes in the intestinal microbiota of 14-year-old or 15-year-old Japanese adolescents: a cross-sectional study. BMJ Open 2021;11:e047941
    https://doi.org/10.1136/bmjopen-2020-047941
  41. M. Pliatsko. Peculiarities of influence of single intragastric administration of H2-histamine receptor blockers of the second (nisatidine) and third (famotidine) generation on acid-peptic and mucoid-electrolyte secretion of the stomach in patients with duodenal ulcer. Lʹviv. klin. visn. 2019;4:39
    https://doi.org/10.25040/lkv2019.04.039
  42. Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito, Robert T. Jensen. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. IJMS 2019;20:5128
    https://doi.org/10.3390/ijms20205128
  43. Jeffrey M. Beckett, Neeraj K. Singh, Jehan Phillips, Krishnakumar Kalpurath, Kent Taylor, Roger A. Stanley, Rajaraman D. Eri. Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study. Nutrients 2020;12:1813
    https://doi.org/10.3390/nu12061813
  44. L. V. Khimion, T. O. Sytiuk, S. V. Danyliuk, O. B. Yashchenko, N. V. Kicha. EFFICACY AND SAFETY OF THE COMPLEX PHYTO MEDICATION IN TREATMENT AND PREVENTION OF THE NSAID-INDUCED DAMAGES OF THE UPPER GASTROINTESTINAL TRACT IN OSTEOARTHRITIS PATIENTS . VPBM 2020;4:230
    https://doi.org/10.29254/2077-4214-2019-4-2-154-230-238
  45. Saira Nayab, Momin Khan, Yerim Cho, Hyosun Lee. Urease inhibition and anti-leishmanial properties of Zn(II) complexes of thiophenyl and furyl-derived C2-symmetric ligands. Journal of Coordination Chemistry 2022;75:2978
    https://doi.org/10.1080/00958972.2022.2143269
  46. Jerin James, Jamuna Rani, Varadarajan Sathyanarayanan, Althab Begum, Syed Hussain Fayaz. Anaphylaxis to Pantoprazole: A Case Report and Prerequisite for Vigilant Prescribing Practises for Proton Pump Inhibitors. CDS 2022;17:78
    https://doi.org/10.2174/1574886316666210728115356
  47. Tahmina Lata, Jodie Trautman, Philip Townend, Robert B Wilson. Current management of gastro-oesophageal reflux disease—treatment costs, safety profile, and effectiveness: a narrative review. 2022;11
    https://doi.org/10.1093/gastro/goad008
  48. O. V. Muslimova, V. A. Evteev, I. A. Mazerkina. Effect of Organic Anion Transporters on the Development of Nephrotoxicity in the Context of NSAIDs Use. Bezopasnost' i risk farmakoterapii 2020;8:198
    https://doi.org/10.30895/2312-7821-2020-8-4-198-204
  49. Sufeng Zhou, Lijun Xie, Chen Zhou, Lu Wang, Juan Chen, Sijia Ding, Bei Zhu, Mei Su, Feng Shao. Keverprazan, a novel potassium‐competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects. Clinical Translational Sci 2023
    https://doi.org/10.1111/cts.13598
  50. A Dua, M Venu. Associated risks of proton pump inhibitors and their influence on prescribing habits: is change truly warranted?. 2019;32
    https://doi.org/10.1093/dote/doy103
  51. Thiruvinvamalai S. Dharmarajan. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing. Journal of the American Medical Directors Association 2021;22:15
    https://doi.org/10.1016/j.jamda.2020.09.046
  52. Hoon Gil Jo, Yong Sung Kim. Helicobacter pylori Eradication Therapy-associated Diarrhea. Korean J Helicobacter Up Gastrointest Res 2021;21:203
    https://doi.org/10.7704/kjhugr.2021.0037
  53. Ana Flávia Seraine Custódio Viana, Hélio B. Fernandes, Mariana H. Chaves, Daniel A. Viana, Verlane G. Santos, Ariadne D. Braga, Ana Candida A. Silva, Miriam T.P. Lopes, Rita de Cássia M. Oliveira. Cenostigma macrophyllumTul. var.acuminataTeles Freire Fraction Leaves Stimulate Gastric Healing in Rats and Human Cell Cultures. Journal of Medicinal Food 2021;24:248
    https://doi.org/10.1089/jmf.2020.0013
  54. Paulien Vinke, Evertine Wesselink, Wout van Orten-Luiten, Klaske van Norren. The Use of Proton Pump Inhibitors May Increase Symptoms of Muscle Function Loss in Patients with Chronic Illnesses. IJMS 2020;21:323
    https://doi.org/10.3390/ijms21010323
  55. Michael Hughes, Yannick Allanore, Murray Baron, Francesco Del Galdo, Christopher P Denton, Tracy Frech, Daniel E Furst, Ilaria Galetti, Lorenzo Dagna, Ariane L Herrick, Masataka Kuwana, Pietro Matucci-Cerinic, Zsuzsanna H McMahan, Charles D Murray, Susanna Proudman, Marco Matucci-Cerinic. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology 2022;4:e795
    https://doi.org/10.1016/S2665-9913(22)00183-7
  56. Mee Yeon Lee, Suhyun Lee, Kyu-Nam Heo, Woo-Youn Kim, Sun Hoi Jung, Young-Mi Ah, Ju-Yeun Lee. Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors. IJGM 2022;Volume 15:2835
    https://doi.org/10.2147/IJGM.S353098
  57. Chongxiang Zhao, Jingwu Wang, Qiang Xiao. Efficacy of Teprenone for Prevention of NSAID-Induced Gastrointestinal Injury: A Systematic Review and Meta-Analysis. Front. Med. 2021;8
    https://doi.org/10.3389/fmed.2021.647494
  58. Hsueh-Chien Chiang, Er-Hsiang Yang, Huang-Ming Hu, Wei-Ying Chen, Wei-Lun Chang, Chung-Tai Wu, Deng-Chyang Wu, Bor-Shyang Sheu, Hsiu-Chi Cheng. An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding. BMC Gastroenterol 2022;22
    https://doi.org/10.1186/s12876-022-02534-0
  59. Sneha Teresa Selvin, Sonu Thomas, Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Prachi Balani. Establishing the Association Between Osteoporosis and Peptic Ulcer Disease: A Systematic Review. 2022
    https://doi.org/10.7759/cureus.27188
  60. Yoshikazu Kinoshita, Norihisa Ishimura, Shunji Ishihara. Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?. 2018;113:1417
    https://doi.org/10.1038/s41395-018-0183-8
  61. Zeyi Zheng, Ziyu Lu, Yani Song. Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis. Front. Pharmacol. 2023;14
    https://doi.org/10.3389/fphar.2023.1244400
  62. Kisan P. Thakkar, Mark Fowler, Staci Keene, Alina Iuga, Evan S. Dellon. Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis. Digestive and Liver Disease 2022;54:1179
    https://doi.org/10.1016/j.dld.2022.03.006
  63. Susan Park, Jin-Won Kwon, Joong-Min Park, Sungsoo Park, Jinseub Hwang, Kyung Won Seo. The characteristics of antireflux surgery compared to proton pump inhibitor treatment in Korea: a nationwide study using claim data from 2007 to 2016. Ann Surg Treat Res 2020;98:254
    https://doi.org/10.4174/astr.2020.98.5.254
  64. Michael Zhang, Clemente Chia, Claire Stanley, Debra J. Phyland, Paul M. Paddle. Diagnostic Utility of Salivary Pepsin as Compared With 24‐Hour Dual pH/Impedance Probe in Laryngopharyngeal Reflux. Otolaryngol.--head neck surg. 2021;164:375
    https://doi.org/10.1177/0194599820951183
  65. Ranran Jia, Fan Zhang, Ni Wu, Wen Xu, Huitao Gao, Bo Liu, Hongyun Wang. Accelerating Development of Benziamidazole-Class Proton Pump Inhibitors: A Mechanism-Based PK/PD Model to Optimize Study Design with Ilaprazole as a Case Drug. Pharmaceutics 2021;13:392
    https://doi.org/10.3390/pharmaceutics13030392
  66. Brian A. Baldo, Nghia H. Pham. Drug Allergy. 2021.
    https://doi.org/10.1007/978-3-030-51740-3_12
  67. Marie Bridoux, Nicolas Simon, Anthony Turpin. Proton Pump Inhibitors and Cancer: Current State of Play. Front. Pharmacol. 2022;13
    https://doi.org/10.3389/fphar.2022.798272
  68. Jumpei Saito, Naho Yakuwa, Noriko Sandaiji, Hiroyo Kawasaki, Kayoko Kaneko, Tomo Suzuki, Akimasa Yamatani, Haruhiko Sago, Atsuko Murashima. Esomeprazole During Pregnancy and Lactation: Esomeprazole Levels in Maternal Serum, Cord Blood, Breast Milk, and the Infant's Serum. Breastfeeding Medicine 2020;15:598
    https://doi.org/10.1089/bfm.2020.0175
  69. Mohammed Alwan Farhan, Abdulwahhab H. Majeed, Nuha A. Imran, Wafaa Sh. Al-Zuhairi, Leqaa A. Mohammed. A Review of Overcome the Side Effect of Digestion Process on the Drugs. EJCS 2021:363
    https://doi.org/10.34198/ejcs.5221.363375
  70. Yoshikazu Kinoshita, Sachiko Oouchi, Takashi Fujisawa. Eosinophilic gastrointestinal diseases – Pathogenesis, diagnosis, and treatment. Allergology International 2019;68:420
    https://doi.org/10.1016/j.alit.2019.03.003
  71. Naohi Isse, Masashi Hashimoto. Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. DTB 2021;59:60
    https://doi.org/10.1136/dtb.2021.235385rep
  72. Isabel J. B. van der Zalm, Tom J. M. Tobé, Susan J. J. Logtenberg. Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. J Med Case Reports 2020;14
    https://doi.org/10.1186/s13256-020-02423-8
  73. Magali P. A. Disdier Moulder, Abby K. Hendricks, Narith N. Ou. Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?. Clinical Cardiology 2020;43:137
    https://doi.org/10.1002/clc.23304
  74. Mohamed Ben‐Eltriki, Carolyn J. Green, Malcolm Maclure, Vijaya Musini, Ken L. Bassett, James M. Wright. Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence. Pharmacology Res & Perspec 2020;8
    https://doi.org/10.1002/prp2.651
  75. Mohamed I. Zanaty, Adel Abdel-Moneim, Yoichiro Kitani, Toshio Sekiguchi, Nobuo Suzuki. Effect of Omeprazole on Osteoblasts and Osteoclasts in vivo and in the in vitro Model Using Fish Scales. Biochemistry Moscow 2021;86:1192
    https://doi.org/10.1134/S0006297921100035
  76. Susan Park, Jin-Won Kwon, Joong-Min Park, Sungsoo Park, Kyung Won Seo. Treatment Pattern and Economic Burden of Refractory Gastroesophageal Reflux Disease Patients in Korea. J Neurogastroenterol Motil 2020;26:281
    https://doi.org/10.5056/jnm19050
  77. Manar Fouli Gaber Ibrahim, Fatma Alzhraa Fouad Abdelbaki Allam. Potential stem cell—Conditioned medium and their derived exosomes versus omeprazole in treatment of experimental model of gastric ulcer. Acta Histochemica 2022;124:151896
    https://doi.org/10.1016/j.acthis.2022.151896
  78. Yu-Xi Li, Fu-Chao Chen, Ting Liu, Zhao-Peng Cai, Keng Chen, Guo-Xue Tang, Jun-Shen Huang, Xiang-Ge Liu, Jia-Jun Huang, Peng Wang, Yu-Wei Liang, Lin Huang, Mahmood S. Choudhery. Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo. Stem Cells International 2020;2020:1
    https://doi.org/10.1155/2020/8829212
  79. Jan Bultas. Are proton pump inhibitors an effective and safe drug not only in the prophylaxis of gastrointestinal bleeding in antithrombotic treatment?. Vnitř Lék 2020;66:169
    https://doi.org/10.36290/vnl.2020.046
  80. Preety Choudhary, Sushama Biswas, Noufal Kandoth, Deepak Tayde, Abhishek Chatterjee, Samit Chattopadhyay, Amitava Das, Snehasikta Swarnakar, Sumit Kumar Pramanik. Graphene quantum dots alleviate ROS-mediated gastric damage. iScience 2022;25:104062
    https://doi.org/10.1016/j.isci.2022.104062
  81. Naina Mohamed Pakkir Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Med J 2023;59:115
    https://doi.org/10.4068/cmj.2023.59.2.115
  82. Johannes Roksund Hov. Editorial: proton pump inhibition – microbial complications beyond dysbiosis. Aliment Pharmacol Ther 2019;50:962
    https://doi.org/10.1111/apt.15495
  83. Elif Nur Barut, Seçkin Engin, İsmail Saygın, Yesim Kaya‐Yasar, Seyma Arici, Sena F. Sezen. Alpha‐lipoic acid: A promising adjuvant for nonsteroidal anti‐inflammatory drugs therapy with improved efficacy and gastroprotection. Drug Development Research 2021;82:844
    https://doi.org/10.1002/ddr.21791
  84. Wisam Sbeit, Hani Abukaes, Helal Said Ahmad, Moeen Sbeit, Itai Kalisky, Lior Katz, Amir Mari, Tawfik Khoury. The possible association of proton pump inhibitor use with acute cholangitis in patients with choledocholithiasis: a multi-center study. Scandinavian Journal of Gastroenterology 2023;58:83
    https://doi.org/10.1080/00365521.2022.2106150
  85. Mikayla Fan, Mark C. Yarema, Adrian Box, Stacey Hume, Katherine J. Aitchison, Chad A. Bousman. Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada. 2021;31:29
    https://doi.org/10.1097/FPC.0000000000000418
  86. Jordan J. Haworth, Nicholas Boyle, Andres Vales, Anthony R. Hobson. The prevalence of intestinal dysbiosis in patients referred for antireflux surgery. Surg Endosc 2021;35:7112
    https://doi.org/10.1007/s00464-020-08229-5
  87. Jaeeun Yang, Jieon Lee, Hyunju Lee, Juyeon Lee, Young Mee Youn, Jae Hong Choi, Yoon-Joo Kim, Hyun Sik Kang, Kyoung Hee Han, Seung Hyo Kim, Ki-Soo Kang. Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?. Pediatr Gastroenterol Hepatol Nutr 2019;22:511
    https://doi.org/10.5223/pghn.2019.22.6.511
  88. Vincenzo Savarino, Elisa Marabotto, Manuele Furnari, Fabiana Zingone, Patrizia Zentilin, Edoardo Savarino. Latest insights into the hot question of proton pump inhibitor safety – a narrative review. Digestive and Liver Disease 2020;52:842
    https://doi.org/10.1016/j.dld.2020.04.020
  89. Raphaela Francelino do Nascimento, Rodrigo de Oliveira Formiga, Flávia Danielle Frota Machado, Igor Rafael Praxedes de Sales, Gedson Moraes de Lima, Edvaldo Balbino Alves Júnior, Giciane Carvalho Vieira, Raquel Fragoso Pereira, Aurigena Antunes de Araújo, Raimundo Fernandes de Araújo Junior, José Maria Barbosa Filho, Leônia Maria Batista. Rosmarinic acid prevents gastric ulcers via sulfhydryl groups reinforcement, antioxidant and immunomodulatory effects. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:2265
    https://doi.org/10.1007/s00210-020-01894-2
  90. Sareh Kamran, Hamed Karimian, Nurain Salehen, Atin Khalajheda, Bushroa Abdul Razak, Nazia Abdul Majid. Acute Toxicity and Gastroprotective Effect of 2-pentadecanone in Ethanol-induced Gastric Mucosal Ulceration in Rats. International J. of Pharmacology 2019;15:944
    https://doi.org/10.3923/ijp.2019.944.952
  91. Mohammed Zawiah, Al-Motassem Yousef, Amer Hayat Khan, Fahmi Y. AL-Ashwal, Amal Matar, Batool ALKhawaldeh, Rand Nassar, Rami Abduljabbar, Abdullah Abdulmajid Abdo Ahmed, John Rovers. Food-drug interactions: Knowledge among pharmacists in Jordan. PLoS ONE 2020;15:e0234779
    https://doi.org/10.1371/journal.pone.0234779
  92. Marie Bridoux, Marie-Cécile Le Deley, Nicolas Bertrand, Nicolas Simon, Dienabou Sylla, Xavier Mirabel, Anthony Turpin. Effects of Proton Pump Inhibitors Intake During Chemoradiotherapy for Rectal Cancer: a Retrospective Cohort Study. J Gastrointest Canc 2023;54:545
    https://doi.org/10.1007/s12029-022-00825-z
  93. L. Brand Brand, S.F. Steyn Steyn, D.W. Wolmarans Wolmarans. Taking the 'sauer' out of sauerkraut : a rapid update on the pathophysiology and treatment of gastro-oesophageal reflux disease. South African General Practitioner 2020;1:42
    https://doi.org/10.36303/SAGP.2020.1.0002
  94. Lihua Peng, Rong Wan, Shengliang Chen, Jimin Wu, Jing Yang, Xiaoxiao Wang, Bin Yan, Huijun Zhao, Fei Pan, Yichao Shi, Weifeng Wang, Jie Ai, Yunsheng Yang. Efficacy of endoscopic anterior fundoplication with a novel ultrasonic surgical endostapler for gastroesophageal reflux disease: Six-month results from a multicenter prospective trial. Endosc Ultrasound 2023;12:128
    https://doi.org/10.4103/EUS-D-21-00244
  95. Mubashira K Sarnaik, Srimy Modi, Yasaswi Pisipati, Sarayoo Vaidya, Naqvi Syed Gaggatur, Aliya H Sange, Natasha Srinivas, Ibrahim Sange. Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol. 2021
    https://doi.org/10.7759/cureus.16744
  96. SylvesterChuks Nwokediuko. COVID-19 and proton pump inhibitor use: Imperative for caution in prescription. Niger J Gastroenterol Hepatol 2020;12:31
    https://doi.org/10.4103/2251-0079.302903
  97. Tae Jin Lee, Dohyun Kim, Jae Cheon Kim, Si Won Ro, Dong Hee Na. Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets. J. Pharm. Investig. 2023;53:323
    https://doi.org/10.1007/s40005-022-00602-x
  98. Junna Wang, Yangpeng Wu, Qiu Bi, Xianglong Zheng, Jingtao Zhang, Wenxiang Huang. Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis. Hepatol Int 2020;14:385
    https://doi.org/10.1007/s12072-019-10010-3
  99. Leiyu Shi, Cheng-Li Lin, Ching-Huang Su, Keng-Chian Lin, Kam-Hang Leong, Yu-Ting Tina Wang, Chien-Feng Kuo, Shin-Yi Tsai. The Risk of Developing Osteoporosis in Hemolytic Anemia—What Aggravates the Bone Loss?. JCM 2021;10:3364
    https://doi.org/10.3390/jcm10153364
  100. Jieun Kang, Rugyeom Lee, Sei Won Lee. Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD. Respir Res 2023;24
    https://doi.org/10.1186/s12931-023-02345-1
  101. Łukasz Lassmann, Matteo Pollis, Agata Żółtowska, Daniele Manfredini. Gut Bless Your Pain—Roles of the Gut Microbiota, Sleep, and Melatonin in Chronic Orofacial Pain and Depression. Biomedicines 2022;10:1528
    https://doi.org/10.3390/biomedicines10071528
  102. Selma Şengiz Erhan , Aytül Buğra , Sevinç Hallaç Keser , Ali Alemdar . Metastatic multiple gastric neuroendocrine tumors with a long history of proton pump inhibitor use: A case report. J Surg Med 2022;6:882
    https://doi.org/10.28982/josam.1038661
  103. Susan Park, Sungsoo Park, Joong-Min Park, Soorack Ryu, Jinseub Hwang, Jin-Won Kwon, Kyung Won Seo. Anti-reflux Surgery Versus Proton Pump Inhibitors for Severe Gastroesophageal Reflux Disease: A Cost-Effectiveness Study in Korea. J Neurogastroenterol Motil 2020;26:215
    https://doi.org/10.5056/jnm19188
  104. Tanvi Patil, Kimberly Murphy, Laura Woodard, Morgan Lebrecht. Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score. Pharmacotherapy 2020;40:1219
    https://doi.org/10.1002/phar.2477
  105. Rafique Umer Harvitkar, Abhijit Joshi. Minimal Invasive Surgery for Gastroesophageal Reflux Disease and Hiatus Hernia—Our Experience: A Case Series with Review of Literature. International Journal of Recent Surgical and Medical Sciences 2021;7:64
    https://doi.org/10.1055/s-0041-1731115
  106. Rochelli Haefliger, Larissa Selbach Dries, Magda Susana Perassolo, Caroline de Oliveira Cardoso. Neuropsychological assessment after long-term omeprazole treatment. Applied Neuropsychology: Adult 2022:1
    https://doi.org/10.1080/23279095.2022.2106570
  107. Fazila Rizvi, Majid Khan, Almas Jabeen, Hina Siddiqui, M. Iqbal Choudhary. Studies on Isoniazid Derivatives through a Medicinal Chemistry Approach for the Identification of New Inhibitors of Urease and Inflammatory Markers. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-019-43082-0
  108. Michael Rudenko. The Role of Co-Factors in Mast Cell Activation. EMJ Allergy Immunol 2023
    https://doi.org/10.33590//emjallergyimmunol/10301305
  109. Maarten M Bruin, Ruud L M Deijkers, Roos Bazuin, Erika P M Elzakker, Bart G Pijls. Proton-pump inhibitors are associated with increased risk of prosthetic joint infection in patients with total hip arthroplasty: a case-cohort study. Acta Orthopaedica 2021;92:431
    https://doi.org/10.1080/17453674.2021.1920687
  110. Fatma Nihan CANKARA, Özlem ÖZMEN, Hasan Basri SAVAŞ, Yasemin ŞAHİN, Caner GÜNAYDIN. Gastroprotective effect of tarantula cubensis extract in the indomethacin-induced peptic ulcer model in rats. 2020;4:278
    https://doi.org/10.30565/medalanya.797406
  111. Ruiyi Deng, Hua Zhang, Yuan Li, Yanyan Shi. Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis. 2023;46:43
    https://doi.org/10.1097/CJI.0000000000000442
  112. Rakesh Kalapala, Arun Karyampudi, Zaheer Nabi, Santosh Darisetty, Nitin Jagtap, Mohan Ramchandani, Rajesh Gupta, Sundeep Lakhtakia, Rajesh Goud, G Venkat Rao, Prateek Sharma, D Nageshwar Reddy. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial. Gut 2022;71:686
    https://doi.org/10.1136/gutjnl-2020-321811
  113. Ann R. Lurati. Effects of Menopause on Appetite and the Gastrointestinal System. Nursing for Women's Health 2018;22:499
    https://doi.org/10.1016/j.nwh.2018.09.004
  114. Jeung Hui Pyo, Tae Jun Kim, Hyuk Lee, Sung Chul Choi, Soo‐Jin Cho, Yoon‐Ho Choi, Yang Won Min, Byung‐Hoon Min, Jun Haeng Lee, Minwoong Kang, Yeong Chan Lee, Jae J Kim. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study. J of Gastro and Hepatol 2021;36:1235
    https://doi.org/10.1111/jgh.15236
  115. Ben Kang. Can proton pump inhibitors cause intestinal inflammation in children?. Korean J Pediatr 2019;62:384
    https://doi.org/10.3345/kjp.2019.00878
  116. Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. 2019.
    https://doi.org/10.2174/9789815051780122010005
  117. Wuyang Jing, Wenlong Luo, Lan Lou. Diagnostic utility of salivary pepsin in laryngopharyngeal reflux: a systematic review and meta-analysis. Brazilian Journal of Otorhinolaryngology 2023;89:339
    https://doi.org/10.1016/j.bjorl.2022.10.050
  118. Mircea Mănuc. Management of patients with NSAIDs-induced gastropathy – short assessments based on the International Consensus on Guiding Recommendations on NSAIDs-induced Gastropathy. Medic.ro 2019;5:10
    https://doi.org/10.26416/MED.131.3.2019.2577
  119. Porfirio Alonso Ruiz-Hurtado, Leticia Garduño-Siciliano, Pilar Domínguez-Verano, Daniela Balderas-Cordero, Gustavo Gorgua-Jiménez, Octavio Canales-Álvarez, María Margarita Canales-Martínez, Marco Aurelio Rodríguez-Monroy. Propolis and Its Gastroprotective Effects on NSAID-Induced Gastric Ulcer Disease: A Systematic Review. Nutrients 2021;13:3169
    https://doi.org/10.3390/nu13093169
  120. Yang Won Min, Danbee Kang, Ju‐Young Shin, Minwoong Kang, Joo Kyung Park, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Poong‐Lyul Rhee, Jae J. Kim, Eliseo Guallar, Juhee Cho, Hyuk Lee. Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study. Aliment Pharmacol Ther 2019;50:760
    https://doi.org/10.1111/apt.15466
  121. Whitney Smith, Natalia Davila. Gastroesophageal reflux disease. 2023;48:24
    https://doi.org/10.1097/01.NPR.0000000000000065
  122. Tai Zhang, Beihua Zhang, Jinkang Xu, Shunping Ren, Shaogang Huang, Zhaohong Shi, Shaoju Guo, Liqun Bian, Ping Wang, Fengyun Wang, Yidong Cai, Xudong Tang. Chinese herbal compound prescriptions combined with Chinese medicine powder based on traditional Chinese medicine syndrome differentiation for treatment of chronic atrophic gastritis with erosion: a multi-center, randomized, positive-controlled clinical trial. Chin Med 2022;17
    https://doi.org/10.1186/s13020-022-00692-7